Aclaris Therapeutics Inc (ACRS)
1.23
-0.01
(-0.81%)
USD |
NASDAQ |
Apr 22, 16:00
1.23
0.00 (0.00%)
Pre-Market: 09:26
Aclaris Therapeutics Cash and Short Term Investments (Quarterly): 119.11M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 119.11M |
| September 30, 2023 | 103.05M |
| June 30, 2023 | 119.78M |
| March 31, 2023 | 170.80M |
| December 31, 2022 | 217.57M |
| September 30, 2022 | 248.06M |
| June 30, 2022 | 248.60M |
| March 31, 2022 | 179.62M |
| December 31, 2021 | 191.41M |
| September 30, 2021 | 197.88M |
| June 30, 2021 | 231.67M |
| March 31, 2021 | 128.30M |
| December 31, 2020 | 54.13M |
| September 30, 2020 | 53.48M |
| June 30, 2020 | 68.12M |
| March 31, 2020 | 79.00M |
| December 31, 2019 | 73.26M |
| September 30, 2019 | 91.43M |
| Date | Value |
|---|---|
| June 30, 2019 | 115.52M |
| March 31, 2019 | 136.76M |
| December 31, 2018 | 167.97M |
| September 30, 2018 | 134.27M |
| June 30, 2018 | 164.60M |
| March 31, 2018 | 186.98M |
| December 31, 2017 | 193.86M |
| September 30, 2017 | 227.85M |
| June 30, 2017 | 170.50M |
| March 31, 2017 | 153.42M |
| December 31, 2016 | 137.22M |
| September 30, 2016 | 84.04M |
| June 30, 2016 | 94.01M |
| March 31, 2016 | 85.25M |
| December 31, 2015 | 84.87M |
| September 30, 2015 | 38.40M |
| June 30, 2015 | 9.853M |
| December 31, 2014 | 16.13M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
53.48M
Minimum
Sep 2020
248.60M
Maximum
Jun 2022
141.62M
Average
119.78M
Median
Jun 2023
Cash and Short Term Investments (Quarterly) Benchmarks
| Aldeyra Therapeutics Inc | 142.82M |
| Akoya Biosciences Inc | 83.12M |
| MSP Recovery Inc | 11.63M |
| Bullfrog AI Holdings Inc | 2.625M |
| Cadrenal Therapeutics Inc | 8.402M |